Expertise in
5
conditions

Caicun Z. Zhou

No. 150 Jimo Road, 
Shanghai, CN 
Expertise in
5
conditions
No. 150 Jimo Road, 
Shanghai, CN 

Overview

Caicun Zhou practices practicing medicine in Shanghai, China.

Zhou is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Lung Metastases, and Tissue Biopsy.

They are actively involved in clinical research, co-authoring 130 peer reviewed articles and participating in 1 clinical trial.

Locations

No. 150 Jimo Road, Shanghai, 200120, China
Other Locations
No. 507, Zheng Min Road, Shanghai, 200433, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA Non-small Cell Lung Cancer With EGFR-mutation: a Randomized, Positive-controlled, Phase 3 Study (EVIDENCE, CCTC-1501)
Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA Non-small Cell Lung Cancer With EGFR-mutation: a Randomized, Positive-controlled, Phase 3 Study (EVIDENCE, CCTC-1501)
Enrollment Status: Unknown
Publish Date: July 20, 2021
Intervention Type: Drug
Study Drugs: Icotinib, Chemotherapy
Study Phase: Phase 3

130 Total Publications

DESTINY-Lung06: trastuzumab deruxtecan and pembrolizumab as first-line treatment for HER2-overexpressing, PD-L1 TPS <50% NSCLC.
DESTINY-Lung06: trastuzumab deruxtecan and pembrolizumab as first-line treatment for HER2-overexpressing, PD-L1 TPS <50% NSCLC.
Journal: Future oncology (London, England)
Published: September 02, 2026

Frequently Asked Questions about Caicun Z. Zhou

Is Caicun Z. Zhou a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?

MediFind is an objective health platform that identifies experts based on real-world data. Caicun Z. Zhou is classified as an Distinguished expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Caicun Z. Zhou participate in research or clinical trials?

Yes. Caicun Z. Zhou has published 130 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Caicun Z. Zhou's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhou's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile